Revance recently appointed Steve Kreider as the new Executive Vice President and Chief Revenue Officer. In this role, he will oversee the U.S. sales strategy for both aesthetics and therapeutics. The company aims to align its commercial goals to ensure long-term growth. This move helps the firm strengthen its market execution. It also improves how the team engages with providers and patients.
“We are excited to welcome Steve to our leadership team,” stated Nadeem Moiz, CEO of Revance. “Steve is a proven leader with deep experience in this industry. His track record of building teams makes him the right choice for us.”
Kreider brings over twenty years of leadership experience to the organization. Previously, he served as a senior executive at Cutera and Ortho Dermatologics. He also held key roles at Merz Aesthetics and Medicis. He successfully managed large sales teams and launched several major products.
Driving Market Impact
Transitioning into this new position allows Kreider to focus on market expansion. He will work closely with the team to elevate brand performance. Consequently, the company expects to unlock new opportunities in the global market.
“Revance has a powerful portfolio and great potential,” Kreider noted. “I am eager to partner with this team to improve our commercial execution. We will build the capabilities needed for long-term success.”
Revance remains a leader in global aesthetics and skincare. The company provides innovative products such as DAXXIFY and RHA Collection. The branded products that it owns include SkinPen and StriVectin. They currently serve patients in over 60 countries. This appointment marks a significant step for the Chief Revenue Officer to guide the firm’s future.
Looking for more updates on financial innovation and revenue-driven technology? Visit RevTech News for expert insights and the latest trends.
News Source: Businesswire.com
